Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2023 Results Conference Call February 2, 2023 8:30 AM ET Company Participants Phil Terpolilli - Vice President of Investor Relations & Treasurer Ronald Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Rupesh Parikh - Oppenheimer and Company Jon Andersen - William Blair Mitchell Pinheiro - Sturdivant & Co Linda Bolton Weiser - D.A. Davidson Operator Good da ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ Commission File Number: 001-32433 PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Ju ...

50 race ENSITIVE EYES Second Quarter FY 2023 Results November 3吋, 2022 RIPLE CLEAN 0 ULTIMATE Prestige Consumer HEALTHCARE Safe Harbor Disclosure This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, diluted EPS, leverage, free cash flow, and organic revenue growth; the Company's ability to execute on its brand-building strategy; ...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q2 2023 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations and Treasurer Ron Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Co. Jon Andersen - William Blair Operator Good day and thank you for standing by. Welcome to the Prestige Consumer Healthcare Second Quarter Earnings Conference Cal ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ Commission File Number: 001-32433 PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other J ...

50 rac RIPLE CLEAN First Quarter FY 2023 Results August 4th, 2022 Prestige Consumer HEALTHCARE O ENSITIVE ULTIMATE Safe Harbor Disclosure This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, diluted EPS, EBITDA, free cash flow, and organic revenue growth; the impact of branded POS on the market share of Hydralyte; the Company's ...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2023 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations and Treasurer Ron Lombardi - Chairman, President and CEO Christine Sacco - Chief Financial Officer Conference Call Participants Chris Neamonitis - Jefferies Jon Andersen - William Blair Mitch Pinheiro - Sturdivant Erica Eiler - Oppenheimer Linda Bolton Weiser - D.A. Davidson Operator Good morning. And welcome to the Prestige Consume ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ Commission File Number: 001-32433 PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisd ...

M a y 6 t h , 2 0 2 2 Full-Year FY 22 Results & Business Attributes Review HEALTHCARE Safe Harbor Disclosure This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, diluted EPS, free cash flow, and organic revenue growth; the Company's ability to perform well in the currently evolving environment, including in light of the impact o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO ______ Commission File Number: 001-32433 PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Inco ...